Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
EXAI Stock | USD 4.03 0.04 1.00% |
Under 53% of Exscientia's investor base is interested to short. The analysis of the overall investor sentiment regarding Exscientia Ltd ADR suggests that many traders are impartial. Exscientia's investor sentiment overview provides quick insight into current market opportunities from investing in Exscientia Ltd ADR. The current market sentiment, together with Exscientia's historical and current headlines, can help investors time the market. In addition, many technical investors use Exscientia ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Exscientia stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Exscientia daily returns and investor perception about the current price of Exscientia Ltd ADR as well as its diversification or hedging effects on your existing portfolios.
Exscientia |
Exscientia plc will report financial results for the fourth quarter and full year ended December 31, 2023, on Thursday, March 21, 2024,
Read at businesswire.com
Exscientia Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Exscientia can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Exscientia Fundamental Analysis
We analyze Exscientia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exscientia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exscientia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Exscientia is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Exscientia ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Exscientia stock to make a market-neutral strategy. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics with similar companies.
Peers
Exscientia Related Equities
ZURA | Zura Bio | 21.82 | ||||
RXRX | Recursion Pharmaceuticals | 3.57 | ||||
RLAY | Relay TherapeuticsInc | 3.41 | ||||
SANA | Sana Biotechnology | 2.59 | ||||
LPTX | Leap Therapeutics | 2.52 | ||||
BPMC | Blueprint Medicines | 2.50 | ||||
ADAP | Adaptimmune Therapeutics | 1.89 | ||||
RVMD | Revolution Medicines | 1.78 | ||||
UBX | Unity Biotechnology | 1.35 | ||||
PIRS | Pieris Pharmaceuticals | 1.03 | ||||
AVIR | Atea PharmaceuticalsI | 0.54 | ||||
PDSB | PDS Biotechnology | 0.31 | ||||
KYMR | Kymera Therapeutics | 0.06 | ||||
ELEV | Elevation Oncology | 0.82 | ||||
LIFE | ATyr Pharma | 1.88 | ||||
GLUE | Monte Rosa | 2.20 | ||||
MREO | Mereo BioPharma | 2.49 | ||||
IPSC | Century Therapeutics | 8.57 |
Check out Exscientia Hype Analysis, Exscientia Correlation and Exscientia Performance. Note that the Exscientia ADR information on this page should be used as a complementary analysis to other Exscientia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Exscientia Stock analysis
When running Exscientia's price analysis, check to measure Exscientia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exscientia is operating at the current time. Most of Exscientia's value examination focuses on studying past and present price action to predict the probability of Exscientia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exscientia's price. Additionally, you may evaluate how the addition of Exscientia to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Exscientia's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exscientia. If investors know Exscientia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exscientia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 0.162 | Quarterly Revenue Growth (0.64) | Return On Assets (0.19) | Return On Equity (0.35) |
The market value of Exscientia ADR is measured differently than its book value, which is the value of Exscientia that is recorded on the company's balance sheet. Investors also form their own opinion of Exscientia's value that differs from its market value or its book value, called intrinsic value, which is Exscientia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exscientia's market value can be influenced by many factors that don't directly affect Exscientia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exscientia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Exscientia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exscientia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.